Clinical Trial News and Research

RSS

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

New study investigates a potential treatment for people diagnosed with monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox.

25 Aug 2022

Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine

Pfizer and BioNTech announced filing an application to the United States Food and Drug Administration for Emergency Use Authorization of a SARS-CoV-2 Omicron BA.4/5-adapted bivalent vaccine.

25 Aug 2022

The risk of adverse reactions when herbal medications are taken with cancer drugs

A new study discusses phytovigilance initiatives based on the real-world use of herbal drugs in cancer along with conventional chemotherapy.

24 Aug 2022

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

T cells used in immunotherapy treatments can get exhausted by the task of fighting cancer cells or get shutdown as they enter tumors.

24 Aug 2022

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Researchers conducted a phase I clinical trial of IN-006, an inhaled monoclonal antibody treatment for COVID-19.

24 Aug 2022

Case report on the post-orgasmic illness treated with antihistamines

Scientists discuss a post-orgasmic illness syndrome patient’s experience of being treated with an antihistamine.

23 Aug 2022

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

A new study examines the potential benefit of the glucokinase activator molecule AZD1656 in the ARCADIA trial.

23 Aug 2022

Clinical trial offers the best treatment option for patients with sight loss as a result of diabetes

A new clinical trial researching treatment for patients with sight loss as a result of diabetes has shown a type of laser treatment to be both cost effective and non-invasive, offering the best option for patients and healthcare providers.

23 Aug 2022

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

“Drug factory” implants show promise in eradicating mesothelioma tumors

Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and a checkpoint inhibitor drug.

22 Aug 2022

Taste rehabilitation method shows potential as a new treatment for taste disorders

Many patients suffer from taste disorders due to a variety of causes, and in recent years the number of such patients has skyrocketed even further due to the COVID-19 epidemic.

22 Aug 2022

Researchers reveal details of two key transition points in the development of pancreatic tumors

Pancreatic cancer has few treatment options and limited survival, with only 9% of patients still living five years after diagnosis.

22 Aug 2022

Serious health events rare in children after COVID-19 vaccine booster, says CDC study

Researchers published the effects of a homologous booster dose of the BNT162b2 COVID-19 vaccine in children aged five to 11 years.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine, in preventing progression to severe COVID-19.

22 Aug 2022

Sanders-Brown director receives $1.5 million grant to advance research on Alzheimer's treatment

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer's disease.

19 Aug 2022

Microneedling more effective than chemical peels for treating acne scars in patients with dark skin

Chemical peels are a common treatment for acne scars, but a Rutgers study finds that microneedling is significantly more effective for patients with dark skin.

19 Aug 2022

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

A study finds that blood tests taken the day of a traumatic brain injury can predict which patients are likely to die or survive with severe disability, allowing clinicians to make decisions earlier on possible treatment of TBI.

19 Aug 2022

New clinical trial may establish a standard of care for patients with oligometastatic kidney cancer

Kidney cancer encompasses a wide spectrum and can present with extensive metastases or just a handful. However, today all patients are treated the same. They all receive medication.

19 Aug 2022

Clinical Trial News and Research

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

New study investigates a potential treatment for people diagnosed with monkeypox

Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine

The risk of adverse reactions when herbal medications are taken with cancer drugs

Using the power of CRISPR to engineer better, stronger, longer-lived T cells

The safety, tolerability, and pharmacokinetics of a muco-trapping monoclonal antibody delivered by inhalation

Case report on the post-orgasmic illness treated with antihistamines

Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19

Clinical trial offers the best treatment option for patients with sight loss as a result of diabetes

Modified TB vaccine could help treat non-muscle invasive bladder cancer

“Drug factory” implants show promise in eradicating mesothelioma tumors

Taste rehabilitation method shows potential as a new treatment for taste disorders

Researchers reveal details of two key transition points in the development of pancreatic tumors

Serious health events rare in children after COVID-19 vaccine booster, says CDC study

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Sanders-Brown director receives $1.5 million grant to advance research on Alzheimer's treatment

Microneedling more effective than chemical peels for treating acne scars in patients with dark skin

Day-of-injury blood tests predict which TBI patients are likely to die or survive with severe disability

New clinical trial may establish a standard of care for patients with oligometastatic kidney cancer

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer